IB
Intrust Bank’s Charles River Laboratories CRL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-1,160
| Closed | -$214K | – | 388 |
|
2024
Q4 | $214K | Sell |
1,160
-991
| -46% | -$183K | 0.02% | 373 |
|
2024
Q3 | $424K | Buy |
2,151
+158
| +8% | +$31.1K | 0.04% | 278 |
|
2024
Q2 | $412K | Sell |
1,993
-43
| -2% | -$8.88K | 0.04% | 274 |
|
2024
Q1 | $552K | Sell |
2,036
-181
| -8% | -$49K | 0.06% | 236 |
|
2023
Q4 | $524K | Sell |
2,217
-132
| -6% | -$31.2K | 0.06% | 237 |
|
2023
Q3 | $460K | Sell |
2,349
-45
| -2% | -$8.82K | 0.06% | 246 |
|
2023
Q2 | $503K | Sell |
2,394
-229
| -9% | -$48.1K | 0.06% | 243 |
|
2023
Q1 | $529K | Sell |
2,623
-372
| -12% | -$75.1K | 0.07% | 231 |
|
2022
Q4 | $653K | Buy |
2,995
+152
| +5% | +$33.1K | 0.09% | 195 |
|
2022
Q3 | $559K | Sell |
2,843
-3
| -0.1% | -$590 | 0.09% | 202 |
|
2022
Q2 | $609K | Sell |
2,846
-201
| -7% | -$43K | 0.09% | 200 |
|
2022
Q1 | $865K | Sell |
3,047
-99
| -3% | -$28.1K | 0.11% | 169 |
|
2021
Q4 | $1.19M | Buy |
3,146
+33
| +1% | +$12.4K | 0.14% | 136 |
|
2021
Q3 | $1.28M | Sell |
3,113
-60
| -2% | -$24.7K | 0.17% | 113 |
|
2021
Q2 | $1.17M | Buy |
3,173
+38
| +1% | +$14.1K | 0.16% | 126 |
|
2021
Q1 | $909K | Buy |
3,135
+128
| +4% | +$37.1K | 0.13% | 145 |
|
2020
Q4 | $751K | Buy |
3,007
+20
| +0.7% | +$5K | 0.11% | 164 |
|
2020
Q3 | $676K | Sell |
2,987
-11
| -0.4% | -$2.49K | 0.12% | 152 |
|
2020
Q2 | $522K | Buy |
2,998
+136
| +5% | +$23.7K | 0.1% | 181 |
|
2020
Q1 | $361K | Sell |
2,862
-300
| -9% | -$37.8K | 0.1% | 207 |
|
2019
Q4 | $483K | Buy |
3,162
+136
| +4% | +$20.8K | 0.11% | 203 |
|
2019
Q3 | $400K | Buy |
3,026
+27
| +0.9% | +$3.57K | 0.1% | 214 |
|
2019
Q2 | $425K | Buy |
2,999
+73
| +2% | +$10.3K | 0.1% | 224 |
|
2019
Q1 | $425K | Sell |
2,926
-18
| -0.6% | -$2.61K | 0.11% | 233 |
|
2018
Q4 | $333K | Buy |
2,944
+599
| +26% | +$67.8K | 0.1% | 244 |
|
2018
Q3 | $316K | Buy |
2,345
+277
| +13% | +$37.3K | 0.08% | 286 |
|
2018
Q2 | $232K | Buy |
+2,068
| New | +$232K | 0.06% | 331 |
|